Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT
1 other identifier
observational
48
1 country
1
Brief Summary
Background: Corona virus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose: To give initial experience about COVID-19 in Alexandria-Egypt describing radiological patterns of lung involvement, also surveying prevalence of co-morbid lung diseases and their effect on COVID-19 presentation. Methods: Retrospective study including 48 patients with positive polymerase chain reaction (PCR) test for COVID-19 during the period from February 2020 till May 2020 in Alexandria/Egypt. Full clinical and laboratory data are obtained. High resolution computed tomography (HRCT) findings are described. Serial follow up studies are done. Surveying co-morbid lung diseases done including tuberculosis (TB), interstitial lung diseases (ILDs), chronic obstructive lung disease (COPD), immune and vascular-related diseases. Prevalence rate is the predominant analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 5, 2020
CompletedFirst Posted
Study publicly available on registry
May 11, 2020
CompletedMay 12, 2020
May 1, 2020
3 months
May 5, 2020
May 10, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Radiological pattern of initial presentation, disease progress, healing and recovery
HRCT findings
"through study completion, an average of 1 month"
Survey of co-morbid lung diseases
prevalence
"through study completion, an average of 1 month"
Eligibility Criteria
Primary care centers
You may qualify if:
- Positive COVID-19
You may not qualify if:
- Incomplete medical records, degrade CT images because of patient tachypnea and motions artifacts, also unremarkable CT scans.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, University of Alexandria
Alexandria, 21526, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Samir, MD
Department of Radio-diagnosis.
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of radio-diagnosis
Study Record Dates
First Submitted
May 5, 2020
First Posted
May 11, 2020
Study Start
February 1, 2020
Primary Completion
April 30, 2020
Study Completion
May 1, 2020
Last Updated
May 12, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
The investigators will recommend further large group future researches for some notices in the study, but preferably not be biased